Latest News...
> PharmE3D Labs Earn Multiple Pharmaceutical Science Distinctions
> 3D Printing In Personalized Drug Delivery
> CoM3D and University of Texas at Austin sign patent license agreement
> CoM3D Secures up to £1M in New Funding
> CoM3D developing hybrid anti-viral delivery systems
> Maniruzzaman Lab collaboration works to develop patient-focused medicines more efficiently
> CoM3D appoints Alastair Syvret to Advisory Panel
> CoM3D appoints Dr Anthony Thomson as CEO.
© 2024 CoM3D Limited | Privacy Policy